EXOC6B expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.219400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.882400E-01
Normal-vs-Stage2
6.934400E-01
Normal-vs-Stage3
3.610200E-01
Normal-vs-Stage4
1.347620E-01
Stage1-vs-Stage2
9.527600E-01
Stage1-vs-Stage3
7.551900E-02
Stage1-vs-Stage4
6.634300E-02
Stage2-vs-Stage3
1.534800E-01
Stage2-vs-Stage4
7.659900E-02
Stage3-vs-Stage4
1.004460E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.422400E-01
Normal-vs-AfricanAmerican
3.740400E-01
Normal-vs-Asian
8.156400E-01
Caucasian-vs-AfricanAmerican
2.127000E-01
Caucasian-vs-Asian
3.054800E-01
AfricanAmerican-vs-Asian
8.852500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.998400E-01
Normal-vs-Female
7.576400E-01
Male-vs-Female
7.227800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.711800E-01
Normal-vs-Age(41-60Yrs)
4.111600E-01
Normal-vs-Age(61-80Yrs)
8.788400E-01
Normal-vs-Age(81-100Yrs)
5.525600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.882000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.349200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.731180E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.020500E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.323620E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.346400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.935400E-01
Normal-vs-Daily Drinker
9.740000E-01
Normal-vs-Weekly Drinker
8.578000E-01
Normal-vs-Occasional Drinker
4.405800E-01
Normal-vs-Social Drinker
5.051600E-01
Non Drinker-vs-Daily Drinker
9.423000E-01
Non Drinker-vs-Weekly Drinker
6.920400E-01
Non Drinker-vs-Occasional Drinker
5.025500E-02
Non Drinker-vs-Social Drinker
1.453040E-01
Daily Drinker-vs-Weekly Drinker
7.089600E-01
Daily Drinker-vs-Occasional Drinker
1.708160E-01
Daily Drinker-vs-Social Drinker
1.894790E-01
Weekly Drinker-vs-Occasional Drinker
3.681800E-01
Weekly Drinker-vs-Social Drinker
3.789800E-01
Occasional Drinker-vs-Social Drinker
8.714800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.732190E-01
Normal-vs-Grade 2
6.498100E-02
Normal-vs-Grade 3
3.723700E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.599960E-01
Grade 1-vs-Grade 3
3.854400E-02
Grade 1-vs-Grade 4
1.732190E-01
Grade 2-vs-Grade 3
2.726000E-01
Grade 2-vs-Grade 4
6.498100E-02
Grade 3-vs-Grade 4
3.723700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.766400E-01
Normal-vs-NonDiabetic
8.352200E-01
Diabetic-vs-NonDiabetic
7.306800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.227600E-01
Normal-vs-NoPancreatitis
7.787400E-01
Pancreatitis-vs-NoPancreatitis
9.932600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.049000E-01
Normal-vs-N1
6.814200E-01
N0-vs-N1
5.644000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.417200E-01
Normal-vs-TP53-NonMutant
6.961400E-01
TP53-Mutant-vs-TP53-NonMutant
4.272200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
